Skip to main content

Canadian Imperial Bank of Commerce(CM-T)
TSX

Today's Change
Real-Time Last Update

Qihan Biotech Unveils its Program to Develop Immunologically Privileged Human Stem Cells for Allogeneic Cell Therapies

Business Wire - Wed Oct 14, 2020
N/A

Provided Content: Content provided by Business Wire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe